SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Raymond James Maintains Outperform on InflaRx, Raises Price Target to $20

Raymond James maintains InflaRx (NASDAQ:IFRX) with a Outperform and raises the price target from $10 to $20.

Benzinga · 05/21/2020 17:44

Raymond James maintains InflaRx (NASDAQ:IFRX) with a Outperform and raises the price target from $10 to $20.